Home Page

Ever wonder what about the ROI on biomedical research looks like? At the Vanderbilt University School of Medicine Basic Sciences, scientists are delivering answers—by driving discoveries that are already improving human health and paving the way for tomorrow’s treatments. From tackling cancer and Alzheimer’s to pioneering antibiotic resistance solutions, we are shaping the future of medicine. This roundup highlights some of the year’s most exciting advances—showing the extraordinary value of sustained support for biomedical science. Read More

Meet Ashley Haddard, the senior program manager for research for the Department of Pharmacology in the Vanderbilt School of Medicine Basic Sciences. Read More

Lisa M. Monteggia and Matthew J. Tyska are among the 471 scientists elected as 2024 fellows of the American Association for the Advancement of Science. Dean John Kuriyan was also recently elected a member of the 2025 class of fellows of the American Association for Cancer Research academy. Read More

Anne Taylor, PhD'23, sat down with us to discuss her experience studying basic science at Vanderbilt and how it played a role in her career. Taylor is now a fellow at the Center for Opioid Research, Education & Outreach at the Auburn University Harrison College of Pharmacy. Read More

2024–25 Global Engagement Funding proposals are due by May 5, 2025. Read More

Meet David Baughman, the research program manager for the Vanderbilt Institute of Chemical Biology. Read More

Triple-negative breast cancer accounts for 10 percent of breast cancer cases in the U.S. annually. As T-cells that normally kill cancer cells often become exhausted and stop, Vanderbilt pharmacologists are seeking chemotherapy or targeted therapy approaches that can enhance the T-cell killing of cancer cells. Read More

“This transformative agreement allows Vanderbilt researchers to benefit from Nature’s tremendous influence and reach,” University Librarian Jon Shaw said. “Our research findings will reach global audiences immediately upon publication, speeding up scientific innovation and progress. This collaboration not only strengthens Vanderbilt’s reputation but will aid in attracting top faculty, students and partnerships to the university.” Read More

New research by Vanderbilt pharmacologists has uncovered inconsistencies in the active ingredient levels of a dietary supplement often referred to as corydalis. The work, published in Frontiers in Pharmacology, highlights concerns regarding the efficacy and authenticity of these widely used supplements. Read More

Ryan Hibbs, professor and chair of neurobiology at the University of California, San Diego, will present the Vanderbilt School of Medicine Basic Sciences Apex Lecture on March 27, 2025. Read More